Advanced Solid Tumour

Oncology

22 drugs in development·4 companies·3 clinical trials

Drug Pipeline by Phase

Phase 3(7)

Drug	Company
azd0022	ASTRAZENECA PLC (AZN)
Ceralasertib	ASTRAZENECA PLC (AZN)
cetuximab	ASTRAZENECA PLC (AZN)
Intravenous Tislelizumab	Merus N.V. (MRUS)
Leucovorin	ASTRAZENECA PLC (AZN)
MEDI4736	ASTRAZENECA PLC (AZN)
Subcutaneous Tislelizumab	Merus N.V. (MRUS)

Phase 2(5)

Drug	Company
azd1775	ASTRAZENECA PLC (AZN)
AZD9592	ASTRAZENECA PLC (AZN)
Infusion of HS-IT101 Injection	Merus N.V. (MRUS)
LILRB4 STAR-T cells injection	Merus N.V. (MRUS)
Tislelizumab Injection	Merus N.V. (MRUS)

Phase 1(6)

Drug	Company
[111in]-fpi-1547	Fusion Pharmaceuticals Inc. (FUSN)
[225ac]-fpi-1434 injection multi-dose	Fusion Pharmaceuticals Inc. (FUSN)
[225ac]-fpi-1434 injection single-dose	Fusion Pharmaceuticals Inc. (FUSN)
fpi-1175 infusion	Fusion Pharmaceuticals Inc. (FUSN)
fpi-1434	Fusion Pharmaceuticals Inc. (FUSN)
PYX-201	Pyxis Oncology, Inc. (PYXS)

Phase 4(4)

Drug	Company
Glucagon for Injection	Merus N.V. (MRUS)
LBL-024 for Injection	Merus N.V. (MRUS)
Rezafungin for Injection	Merus N.V. (MRUS)
Vabysmo 6 MG in 0.05 ML Injection	Merus N.V. (MRUS)

Compare drugs

azd0022 vs Ceralasertib azd0022 vs cetuximab azd0022 vs Intravenous Tislelizumab

Frequently asked questions

How many drugs are in development for Advanced Solid Tumour?

BioSniper tracks 22 drugs in development for Advanced Solid Tumour across 4 companies.

How many clinical trials target Advanced Solid Tumour?

There are 3 clinical trials targeting Advanced Solid Tumour tracked by BioSniper.

Deep-dive into Advanced Solid Tumour

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis

Advanced Solid Tumour — Drugs in Development & Clinical Trials | BioSniper